Literature DB >> 19784697

Peritoneal carcinomatosis from ovarian cancer: the role of CT and [¹⁸F]FDG-PET/CT.

L Funicelli1, L L Travaini, F Landoni, G Trifirò, L Bonello, M Bellomi.   

Abstract

PURPOSE: The diagnosis of peritoneal carcinomatosis secondary to ovarian cancer is a real challenge in the cancer imaging field. In this retrospective study, we evaluate the accuracy of Single Detector Computed Tomography (SDCT), Multi Detector Computed Tomography (MDCT), and Positron Emission Tomography-Computed Tomography with F18-fluorodeoxyglucose ([¹⁸F]FDG-PET/CT) in the diagnosis of peritoneal seeding and we evaluate the possible applications of MDCT to predict the complete surgical removal of the peritoneal deposits. METHODS AND MATERIALS: A total of 228 scans (91 SDCT, 89 MDCT, and 48 [¹⁸F]FDG-PET/CT) of patients with peritoneal carcinomatosis secondary to ovarian cancer proved at laparoscopy and confirmed by histopathology were retrospectively reviewed by two independent groups of Radiologists and Nuclear Medicine Physicians for the evaluation of ascites, peritoneal nodules, and omental cake signs.
RESULTS: MDCT showed 81% of true positives, SDCT 72.5%, and [¹⁸F]FDG-PET/CT 77%. False negatives were 19% for MDCT, 27.5% for SDCT, and 23% for [¹⁸F]FDG-PET/CT.
CONCLUSION: From our results, we concluded that MDCT is the technique of choice in the diagnosis of peritoneal seeding, while [¹⁸F]FDG-PET/CT, though showing similar accuracy, remains the most accurate technique for monitoring therapeutic response and disease recurrence. MDCT could play an important role due to its ability to predict the possibility of complete surgical removal of disease thus influencing the treatment plan aimed to improve quality of life.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19784697     DOI: 10.1007/s00261-009-9578-8

Source DB:  PubMed          Journal:  Abdom Imaging        ISSN: 0942-8925


  11 in total

1.  Management of Peritoneal Carcinomatosis With Cytoreductive Surgery Combined With Intraperitoneal Chemohyperthermia at a Novel Italian Center.

Authors:  Pinuccia Faviana; Laura Boldrini; Barbara Musco; Mauro Ferrari; Alfonso Greco; Lorenzo Fornaro; Gianluca Masi; Francesco Forfori; Sergio Ricci; Augusto Brogi; Fulvio Basolo; Alfredo Falcone; Angelo Gadducci; Piero Vincenzo Lippolis
Journal:  In Vivo       Date:  2020 Jul-Aug       Impact factor: 2.155

Review 2.  Intraoperative imaging in ovarian cancer: fact or fiction?

Authors:  Lucia M A Crane; Marleen van Oosten; Rick G Pleijhuis; Arash Motekallemi; Sean C Dowdy; William A Cliby; Ate G J van der Zee; Gooitzen M van Dam
Journal:  Mol Imaging       Date:  2011-04-26       Impact factor: 4.488

Review 3.  Diagnostic accuracy of 18F-FDG PET/CT for detection of peritoneal carcinomatosis; a systematic review and meta-analysis.

Authors:  Seong-Jang Kim; Sang-Woo Lee
Journal:  Br J Radiol       Date:  2017-11-21       Impact factor: 3.039

4.  Oral gastrografin radiography for the evaluation of the functional impact of peritoneal carcinomatosis: Correlation with clinicopathological findings.

Authors:  Lie-Jun Mei; Lin-Wei Wang; Chao-Qun Huang; Xiao-Jun Yang; Yan Li
Journal:  Mol Clin Oncol       Date:  2015-06-09

5.  EANM guideline on the role of 2-[18F]FDG PET/CT in diagnosis, staging, prognostic value, therapy assessment and restaging of ovarian cancer, endorsed by the American College of Nuclear Medicine (ACNM), the Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the International Atomic Energy Agency (IAEA).

Authors:  Roberto C Delgado Bolton; Nicolas Aide; Patrick M Colletti; Annamaria Ferrero; Diana Paez; Andrea Skanjeti; Francesco Giammarile
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-07-03       Impact factor: 9.236

6.  Peritoneal carcinomatosis from ovarian cancer: chemosensitivity test and tissue markers as predictors of response to chemotherapy.

Authors:  Chiara Arienti; Anna Tesei; Giorgio Maria Verdecchia; Massimo Framarini; Salvatore Virzì; Antonio Grassi; Emanuela Scarpi; Livia Turci; Rosella Silvestrini; Dino Amadori; Wainer Zoli
Journal:  J Transl Med       Date:  2011-06-20       Impact factor: 5.531

Review 7.  PET/MRI in Oncological Imaging: State of the Art.

Authors:  Usman Bashir; Andrew Mallia; James Stirling; John Joemon; Jane MacKewn; Geoff Charles-Edwards; Vicky Goh; Gary J Cook
Journal:  Diagnostics (Basel)       Date:  2015-07-21

8.  Performance of pre-treatment ¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography for detecting metastasis in ovarian cancer: a systematic review and meta-analysis.

Authors:  Sangwon Han; Sungmin Woo; Chong Hyun Suh; Jong Jin Lee
Journal:  J Gynecol Oncol       Date:  2018-11       Impact factor: 4.401

9.  The ability of whole-body SUVmax in F-18 FDG PET/CT to predict suboptimal cytoreduction during primary debulking surgery for advanced ovarian cancer.

Authors:  Gun Oh Chong; Shin Young Jeong; Yoon Hee Lee; Hyun Jung Lee; Sang-Woo Lee; Hyung Soo Han; Dae Gy Hong; Yoon Soon Lee
Journal:  J Ovarian Res       Date:  2019-02-04       Impact factor: 4.234

10.  Diffusion-Weighted Magnetic Resonance Imaging as a Noninvasive Parameter for Differentiating Benign and Malignant Intraperitoneal Collections.

Authors:  Paul-Andrei Ștefan; Csaba Csutak; Andrei Lebovici; Georgeta Mihaela Rusu; Carmen Mihaela Mihu
Journal:  Medicina (Kaunas)       Date:  2020-05-01       Impact factor: 2.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.